ASCO highlights new findings on cancer screening discoveries connected to ovarian, cervical, and prostate cancers

Cancer

Volumn 117, Issue 16, 2011, Pages 3627-3628

  Printz, Carrie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; GENE TRANSLOCATION; GYNECOLOGIC SURGERY; HUMAN; MEDICAL SOCIETY; OVARY CANCER; PAPANICOLAOU TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RISK ASSESSMENT; TRANSVAGINAL ECHOGRAPHY; URINALYSIS; UTERINE CERVIX CANCER; WART VIRUS;

EID: 80051506745     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26399     Document Type: Article

References (1)

1. Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009; 10: 327-340.